Opens in a new tab

Edwards Lifesciences v Meril (CFI, ORD_56918/2024, 15 November 2024)

Date15 November 2024
CourtCFI
DivisionMunich (DE) Local Division
Type of actionGeneric application
Registry referenceApp_56354/2024 · ORD_56918/2024
PartiesMeril Gmbh, Meril Life Sciences Pvt Ltd.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 15 November 2024 (UPC_CFI_15/2023, ACT_459987/2023, ORD_56918/2024), the Munich Local Division (Judges Zigann, presiding and rapporteur, Kokke, Pichlmaier and technically qualified judge Wilhelm), in Edwards Lifesciences’ action for infringement of EP 3 646 825 against Meril GmbH and Meril Life Sciences, rejected the defendants’ request, filed on 16 October 2024 after the hearing of 24 September, that the Court ask the European Commission about possible abuse of dominance investigations (Art. 102 TFEU) concerning the claimant, and that they be allowed to file further pleadings or have the hearing reopened. The order confirms that once the proceedings have closed, further pleadings are in principle ruled out.

Question

Can a party, after the written procedure, the interim procedure and the oral hearing have closed, obtain an inquiry addressed to the Commission and leave to file further pleadings?

Decision

The Court may disregard late steps and arguments (Rule 9.2), and further pleadings require a reasoned request before the judge-rapporteur closes the written procedure (Rule 36). The written and interim procedures and the hearing had ended, and no post-hearing submissions had been allowed. The request therefore fell outside any open procedural stage. Granting it would have jeopardised the decision date set for 15 November 2024. Moreover, the Court had already asked for an update at the hearing. The claimant had confirmed that nothing had changed and that the Commission had opened no formal investigation, and the defendants alleged no new fact.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 52(1) and 73(2)(b)
Rules of Procedure
Rules 9.2, 36, 102.1, 220.2 and 224.1(b)
Case law cited
Relied on by the claimant: NanoString v President and Fellows of Harvard College, Munich Central Division, 25 July 2024, Carrier v BITZER Electronics, Court of Appeal, 28 May 2024.

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
La demande, formée après l'audience, tendant à interroger la Commission européenne et à déposer de nouvelles écritures est rejetée comme tardive et inutile.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 646 825
A system comprising a prosthetic valve and a delivery catheter
recorded proprietor: Edwards Lifesciences Corp
Mentioned in the analysis (role not qualified)
Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.